Another study points out the importance of AKT3 in TNBC by reporting amplification of AKT3 in 14% of TNBC versus 3% of luminal breast cancer and upregulation of mRNA in 21% of TNBC versus 2% of luminal human breast cancer according to a TCGA analysis [151]. The gene discussed is AKT3; the disease is breast carcinoma.